Brief: Pharnext FY Operating Loss Widens To 27.8 Million Euros
April 28 (Reuters) - Pharnext SA PHARN.PA :
* ANNOUNCES ITS 2022 ANNUAL FINANCIAL RESULTS
* FY NET RESULT -38 446 KEUR VERSUS -30 618 KEUR YEAR AGO
* FY OPERATING RESULT -27.8 MEUR VERSUS -22.9 MEUR YEAR AGO
* FROM END 2022 IMPLEMENTS DRASTIC REVIEW OF ALL OF THESE
CHARGES
IN ORDER TO SIGNIFICANTLY REDUCE ITS CASH REQUIREMENTS FOR THE
WHOLE OF 2023
Source text for Eikon: ID:nACT79657
Further company coverage: PHARN.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Pharnext SCA
See all newsBrief: Pharnext Progresses On Charcot-Marie-Tooth Disease Study
Brief: Pharnext Reports Topline Results From Pivotal Phase III Clinical Trial Of PXT3003 In Charcot-Marie-Tooth Disease Type 1A
Brief: Pharnext Receives Offer Valuing Its Drug Candidate For Charcotmarie-Tooth Disease At Over Eur 500 Mln
Brief: Pharnext Appoints Dr Gilbert Wagener As Chief Medical Officer
Brief: Pharnext Reports Significant Progress In Search For Pharmaceutical Partners To Finance Its Development